SEC Form 4 · accession 0001144204-15-009282

Harvard Apparatus Regenerative Technology, Inc. · HRGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Feb 12, 2015

Accepted (ET)

Feb 13, 2015 · 8:13 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001563665

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F3	Feb 12, 2015	P	10,500	$2.59	A	31,628	D
Common Stock^F2,F4	Feb 13, 2015	P	3,500	$2.91	A	35,128	D

No Table II lines on this filing.

F1This transaction was executed in multiple trades at prices ranging from $2.52 to $2.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2This transaction was executed in multiple trades at prices ranging from $2.81 to $2.95. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 30,523 shares of common stock held by the Reporting Person.
F4Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 34,023 shares of common stock held by the Reporting Person.

This form has been signed under power of attorney.